Literature DB >> 12181167

Poly(ADP-ribose) polymerase triggers the microvascular mechanisms of hepatic ischemia-reperfusion injury.

Andrej Khandoga1, Georg Enders, Peter Biberthaler, Fritz Krombach.   

Abstract

Activation of poly(ADP-ribose) polymerase (PARP) mediates oxidative stress-induced cell injury. We tested the hypothesis that PARP contributes to ischemia-reperfusion (I/R) damage of the liver by triggering the mechanisms of microcirculatory failure. Leukocyte- and platelet-endothelial cell interactions as well as sinusoidal perfusion were analyzed by intravital fluorescence microscopy after lobar hepatic I/R (90 min/30 min) in C57BL/6 x 129/Sv wild-type (PARP+/+) and PARP-deficient (PARP-/-) mice. Hepatic I/R induced leukocyte/platelet-endothelial cell interactions and tissue injury in PARP+/+ mice, as indicated by impaired sinusoidal perfusion and increased alanine aminotransferase (ALT)/aspartate aminotransferase (AST) serum activities. In PARP-/- mice, however, the postischemic increase in the numbers of rolling/adherent leukocytes and platelets was significantly lower. In addition, I/R-induced translocation of CD62P as well as mRNA expression of CD62E, CD54, and CD106 were attenuated. The degree of perfusion failure was reduced and the increase in the ALT/AST activities was lower in PARP-/- mice compared with PARP+/+ mice. We conclude that PARP contributes to hepatic microvascular injury by triggering the expression/translocation of adhesion molecules and modulating leukocyte/platelet-endothelial cell interactions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12181167     DOI: 10.1152/ajpgi.00085.2002

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  7 in total

1.  Mild hypothermia protects liver against ischemia and reperfusion injury.

Authors:  Cheng-You Wang; Yong Ni; Yan Liu; Zhi-Heng Huang; Min-Jie Zhang; Yong-Qiang Zhan; Hai-Bin Gao
Journal:  World J Gastroenterol       Date:  2005-05-21       Impact factor: 5.742

2.  Protective effects of PARP inhibition on liver microcirculation and function after haemorrhagic shock and resuscitation in male rats.

Authors:  J P Roesner; D A Vagts; T Iber; C Eipel; B Vollmar; G F E Nöldge-Schomburg
Journal:  Intensive Care Med       Date:  2006-08-23       Impact factor: 17.440

3.  Anti-inflammatory effects of PJ34, a poly(ADP-ribose) polymerase inhibitor, in transient focal cerebral ischemia in mice.

Authors:  M Haddad; H Rhinn; C Bloquel; B Coqueran; C Szabó; M Plotkine; D Scherman; I Margaill
Journal:  Br J Pharmacol       Date:  2006-07-24       Impact factor: 8.739

4.  Effect of tetramethylpyrazine on P-selectin and hepatic/renal ischemia and reperfusion injury in rats.

Authors:  Jin-Lian Chen; Tong Zhou; Wei-Xiong Chen; Jin-Shui Zhu; Ni-Wei Chen; Ming-Jun Zhang; Yun-Lin Wu
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

Review 5.  Molecular mechanisms of liver ischemia reperfusion injury: insights from transgenic knockout models.

Authors:  Gourab Datta; Barry J Fuller; Brian R Davidson
Journal:  World J Gastroenterol       Date:  2013-03-21       Impact factor: 5.742

6.  Hepatocyte-specific high-mobility group box 1 deletion worsens the injury in liver ischemia/reperfusion: a role for intracellular high-mobility group box 1 in cellular protection.

Authors:  Hai Huang; Gary W Nace; Kerry-Ann McDonald; Sheng Tai; John R Klune; Brian R Rosborough; Qing Ding; Patricia Loughran; Xiaorong Zhu; Donna Beer-Stolz; Eugene B Chang; Timothy Billiar; Allan Tsung
Journal:  Hepatology       Date:  2014-04-01       Impact factor: 17.425

7.  The poly(adenosine diphosphate-ribose) polymerase inhibitor PJ34 reduces pulmonary ischemia-reperfusion injury in rats.

Authors:  Go Hatachi; Tomoshi Tsuchiya; Takuro Miyazaki; Keitaro Matsumoto; Naoya Yamasaki; Naoyuki Okita; Atsushi Nanashima; Yoshikazu Higami; Takeshi Nagayasu
Journal:  Transplantation       Date:  2014-09-27       Impact factor: 4.939

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.